Cargando…

Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot

BACKGROUND: Patients with tetralogy of Fallot (ToF) are considered at high risk of infective endocarditis (IE) as a result of altered hemodynamics and multiple invasive procedures, including pulmonary valve replacement (PVR). Data on the long‐term risk of IE are sparse. METHODS AND RESULTS: In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Havers‐Borgersen, Eva, Butt, Jawad H., Smerup, Morten, Gislason, Gunnar H., Torp‐Pedersen, Christian, Gröning, Mathis, Schmidt, Michael Rahbek, Søndergaard, Lars, Køber, Lars, Fosbøl, Emil L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751965/
https://www.ncbi.nlm.nih.gov/pubmed/34730003
http://dx.doi.org/10.1161/JAHA.121.022445
_version_ 1784631793097375744
author Havers‐Borgersen, Eva
Butt, Jawad H.
Smerup, Morten
Gislason, Gunnar H.
Torp‐Pedersen, Christian
Gröning, Mathis
Schmidt, Michael Rahbek
Søndergaard, Lars
Køber, Lars
Fosbøl, Emil L.
author_facet Havers‐Borgersen, Eva
Butt, Jawad H.
Smerup, Morten
Gislason, Gunnar H.
Torp‐Pedersen, Christian
Gröning, Mathis
Schmidt, Michael Rahbek
Søndergaard, Lars
Køber, Lars
Fosbøl, Emil L.
author_sort Havers‐Borgersen, Eva
collection PubMed
description BACKGROUND: Patients with tetralogy of Fallot (ToF) are considered at high risk of infective endocarditis (IE) as a result of altered hemodynamics and multiple invasive procedures, including pulmonary valve replacement (PVR). Data on the long‐term risk of IE are sparse. METHODS AND RESULTS: In this observational cohort study, all patients with ToF born from 1977 to 2018 were identified using Danish nationwide registries and followed from date of birth until occurrence of first‐time IE, emigration, death, or end of study (December 31, 2018). The comparative risk of IE among patients with ToF versus age‐ and sex‐matched controls from the background population was assessed. Because of rules on anonymity, exact numbers cannot be reported if the number of patients is <4. A total of 1164 patients with ToF were identified and matched with 4656 controls. Among patients with ToF, 851 (73.1%) underwent early surgical intracardiac repair and 276 (23.7%) underwent PVR during follow‐up. During a median follow‐up of 20.3 years, 41 (3.5%) patients with ToF (comprising 24 [8.7%] with PVR and 17 [1.9%] without PVR) and <4 (<0.8%) controls were admitted with IE. The incidence rates of IE per 10 000 person‐years were 22.4 (95% CI, 16.5–30.4) and 0.1 (95% CI, 0.01–0.7) among patients and controls, respectively. Moreover, PVR was associated with a further increased incidence of IE among patients with ToF (incidence rates per 10 000 person‐years with and without PVR were 46.7 [95% CI, 25.1–86.6] and 2.8 [95% CI 2.0–4.0], respectively). CONCLUSIONS: Patients with ToF are associated with a substantially higher incidence of IE than the background population. In particular, PVR was associated with an increased incidence of IE. With an increasing life expectancy of these patients, intensified awareness, preventive measures, and surveillance of this patient group are decisive.
format Online
Article
Text
id pubmed-8751965
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87519652022-01-14 Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot Havers‐Borgersen, Eva Butt, Jawad H. Smerup, Morten Gislason, Gunnar H. Torp‐Pedersen, Christian Gröning, Mathis Schmidt, Michael Rahbek Søndergaard, Lars Køber, Lars Fosbøl, Emil L. J Am Heart Assoc Original Research BACKGROUND: Patients with tetralogy of Fallot (ToF) are considered at high risk of infective endocarditis (IE) as a result of altered hemodynamics and multiple invasive procedures, including pulmonary valve replacement (PVR). Data on the long‐term risk of IE are sparse. METHODS AND RESULTS: In this observational cohort study, all patients with ToF born from 1977 to 2018 were identified using Danish nationwide registries and followed from date of birth until occurrence of first‐time IE, emigration, death, or end of study (December 31, 2018). The comparative risk of IE among patients with ToF versus age‐ and sex‐matched controls from the background population was assessed. Because of rules on anonymity, exact numbers cannot be reported if the number of patients is <4. A total of 1164 patients with ToF were identified and matched with 4656 controls. Among patients with ToF, 851 (73.1%) underwent early surgical intracardiac repair and 276 (23.7%) underwent PVR during follow‐up. During a median follow‐up of 20.3 years, 41 (3.5%) patients with ToF (comprising 24 [8.7%] with PVR and 17 [1.9%] without PVR) and <4 (<0.8%) controls were admitted with IE. The incidence rates of IE per 10 000 person‐years were 22.4 (95% CI, 16.5–30.4) and 0.1 (95% CI, 0.01–0.7) among patients and controls, respectively. Moreover, PVR was associated with a further increased incidence of IE among patients with ToF (incidence rates per 10 000 person‐years with and without PVR were 46.7 [95% CI, 25.1–86.6] and 2.8 [95% CI 2.0–4.0], respectively). CONCLUSIONS: Patients with ToF are associated with a substantially higher incidence of IE than the background population. In particular, PVR was associated with an increased incidence of IE. With an increasing life expectancy of these patients, intensified awareness, preventive measures, and surveillance of this patient group are decisive. John Wiley and Sons Inc. 2021-11-03 /pmc/articles/PMC8751965/ /pubmed/34730003 http://dx.doi.org/10.1161/JAHA.121.022445 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Havers‐Borgersen, Eva
Butt, Jawad H.
Smerup, Morten
Gislason, Gunnar H.
Torp‐Pedersen, Christian
Gröning, Mathis
Schmidt, Michael Rahbek
Søndergaard, Lars
Køber, Lars
Fosbøl, Emil L.
Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot
title Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot
title_full Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot
title_fullStr Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot
title_full_unstemmed Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot
title_short Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot
title_sort incidence of infective endocarditis among patients with tetralogy of fallot
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751965/
https://www.ncbi.nlm.nih.gov/pubmed/34730003
http://dx.doi.org/10.1161/JAHA.121.022445
work_keys_str_mv AT haversborgerseneva incidenceofinfectiveendocarditisamongpatientswithtetralogyoffallot
AT buttjawadh incidenceofinfectiveendocarditisamongpatientswithtetralogyoffallot
AT smerupmorten incidenceofinfectiveendocarditisamongpatientswithtetralogyoffallot
AT gislasongunnarh incidenceofinfectiveendocarditisamongpatientswithtetralogyoffallot
AT torppedersenchristian incidenceofinfectiveendocarditisamongpatientswithtetralogyoffallot
AT groningmathis incidenceofinfectiveendocarditisamongpatientswithtetralogyoffallot
AT schmidtmichaelrahbek incidenceofinfectiveendocarditisamongpatientswithtetralogyoffallot
AT søndergaardlars incidenceofinfectiveendocarditisamongpatientswithtetralogyoffallot
AT køberlars incidenceofinfectiveendocarditisamongpatientswithtetralogyoffallot
AT fosbølemill incidenceofinfectiveendocarditisamongpatientswithtetralogyoffallot